Key Market Indicators
Portuguese antirheumatic medicine sales are expected to drop to $75 million by 2026. The market has been in decline since 2005, with an average rate of 3.7% year on year. In 2021, Portugal was the seventh-largest market for the product, with $98.45 million in sales. Belgium was in first place, followed by Germany, Spain and Canada, which made up the top four.
